Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

SHA:603079 Revenue

Zhejiang Shengda Bio-Pharm had revenue of 197.50M CNY in the quarter ending June 30, 2025, a decrease of -1.07%. This brings the company's revenue in the last twelve months to 839.82M, up 6.01% year-over-year. In the year 2024, Zhejiang Shengda Bio-Pharm had annual revenue of 827.40M with 13.75% growth.

• Revenue (ttm): 839.82M
• Revenue Growth: +6.01%
• P/S Ratio: 4.27
• Revenue / Employee: 811.42K
• Employees: 1,035
• Market Cap: 3.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	827.40M	100.00M	13.75%
Dec 31, 2023	727.41M	-10.61M	-1.44%
Dec 31, 2022	738.02M	-51.71M	-6.55%
Dec 31, 2021	789.73M	-77.58M	-8.95%
Dec 31, 2020	867.31M	348.16M	67.06%